Safety and efficacy of a novel toothbrush utilizing RF energy for the reduction of plaque, calculus and gingivitis.
| Autor: | Milleman KR; Salus Research, Fort Wayne, IN, USA., Levi L; Home Skinovations, Ltd., Yokneam, Israel, lioral@silkn.com., Grahovac TL; Salus Research, Fort Wayne, IN, USA., Milleman JL; Salus Research, Fort Wayne, IN, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | American journal of dentistry [Am J Dent] 2020 Jun; Vol. 33 (3), pp. 151-156. |
| Abstrakt: | Purpose: To evaluate the safety and efficacy of the ToothWave radiofrequency (RF) toothbrush in the reduction of plaque, calculus and gingival inflammation, as compared to a standard powered toothbrush accepted by the American Dental Association (ADA). Methods: This was a single-blind, double arm, prospective study. Subjects were randomized to one of two treatment groups, receiving either the RF powered toothbrush or a control powered toothbrush, and performing twice daily brushing for a test period of 6 weeks. Plaque (RMNPI), calculus (V-MI), gingival inflammation (MGI) and bleeding (GBI) were assessed at baseline, after 4 and 6 weeks. Comparisons were completed both within and between each treatment group. Statistical analyses were conducted using the Mann Whitney non-parametric model. Results: 85 subjects completed the study and had fully evaluable data. No significant differences between the groups were found in the baseline scores (P≥ 0.165). Following 6 weeks, the RF test group demonstrated statistically significant reductions in plaque, gingivitis and calculus compared to the control powered toothbrush (P≤ 0.001). Both toothbrushes were well-tolerated and no device-related adverse events were reported. The RF-utilizing powered toothbrush produced statistically significant reductions in dental plaque, calculus deposition, gingival inflammation and gingival bleeding as compared to a control powered toothbrush. Clinical Significance: The RF powered toothbrush used twice daily resulted in an overall improvement in oral health. Competing Interests: Ms. K.R. Milleman, Dr. J.L. Milleman, and Mr. Grahovac declared no conflict of interest. Dr. Levi is Director of Clinical Affairs, Home Skinovations, Ltd. This study was funded by Home Skinovations, Ltd. (Copyright©American Journal of Dentistry.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|